Skip to main content
See who owns your news
Get Started
SubscribeLogin
Published • loading... • Updated

Success with GLP-1-RA in Children and Adolescents with Type 2 Diabetes Also in Clinical Practice

Summary by Deutsches Ärzteblatt
Ulm – A therapy with GLP-1 receptor agonists (GLP1-RA) reduces weight and systolic blood pressure in children and adolescents with type 2 diabetes (T2D) and improves blood glucose control. Data from three European countries are now showing that the use of these drugs has increased rapidly in recent years.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Deutsches ÄrzteblattDeutsches Ärzteblatt

Success with GLP-1-RA in Children and Adolescents with Type 2 Diabetes Also in Clinical Practice

Ulm – A therapy with GLP-1 receptor agonists (GLP1-RA) reduces weight and systolic blood pressure in children and adolescents with type 2 diabetes (T2D) and improves blood glucose control. Data from three European countries are now showing that the use of these drugs has increased rapidly in recent years.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news on Tuesday, October 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Ulm, Germany icon

Ulm, Germany

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal